Research / GIS / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-20-186469 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
62.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.86% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
4.51% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
8.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
34.78% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
16.76% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.27% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.54% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 31 states Self-history eligible
Nov 28, 2021 7/8 normalized Level 3 Feb 27, 2022 8/8 normalized Level 3 May 29, 2022 8/9 normalized Level 3 Aug 28, 2022 8/8 normalized Level 3 Nov 27, 2022 8/8 normalized Level 3 Feb 26, 2023 8/8 normalized Level 3 May 28, 2023 8/9 normalized Level 3 Aug 27, 2023 8/8 normalized Level 3 Nov 26, 2023 8/8 normalized Level 3 Feb 25, 2024 8/8 normalized Level 3 May 26, 2024 8/9 normalized Level 3 Aug 25, 2024 8/8 normalized Level 3 Nov 24, 2024 8/8 normalized Level 3 Feb 23, 2025 8/8 normalized Level 3 May 25, 2025 8/9 normalized Level 3 Aug 24, 2025 8/8 normalized Level 3 Nov 23, 2025 8/8 normalized Level 3 Feb 22, 2026 8/8 normalized Level 3 May 31, 2026 8/9 normalized Level 3 Aug 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 326.00%
Current 62.00%
Delta -264.00% Capex Intensity Decreased
Previous 2.65%
Current 2.61%
Delta -0.04% Cash Generation Increased
Previous 16.82%
Current 20.86%
Delta 4.03% Growth Increased
Previous -0.43%
Current 4.51%
Delta 4.94% Inventory Pressure Decreased
Previous 36.89%
Current 8.09%
Delta -28.80% Margin Increased
Previous 33.57%
Current 34.78%
Delta 1.21% Profitability Increased
Previous 15.57%
Current 16.76%
Delta 1.19% Sbc Intensity Increased
Previous 0.44%
Current 0.54%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.